The most frequent KMT2A partners for B-ALL are AF4 (57%) and ENL (~18%), while the ones for T-ALL are MLLT4 (39%) and MLLT1 (37%) [4]. The gene discussed is AFDN; the disease is acute lymphoblastic leukemia.